Categories

3 in 4 U.S. Patients Say the Healthcare System is Broken — But Technology Can Help

Patients “yearn” for personalized services and relationships in health care — optimistic that technology can help deliver on that hope — we learn in Healthcare’s Future: Balancing Progress and Perception, a health consumer survey report from Lavidge. Lavidge, a communications/PR/marketing consultancy, polled U.S. patients’ attitudes about health care and technology in June 2024, publishing the report earlier this month.                   Start with over-arching finding that, “Three out of four patients believe the U.S. healthcare system is broken and there is a strong sense of distrust,” Lavidge asserts right at the top of

 

What Stays True for U.S. Health Care Post #Election2024 (1) – Consumers’ Dissatisfaction with Drug Prices

For health care, there are many uncertainties as we reflect, one week after the 2024 U.S. elections, on probably policy and market impacts that we can expect in 2025 and beyond. In today’s Health Populi post, I’ll reflect on the first of several certainties we-know-we-know about U.S. health citizens and key factors shaping the American health ecosystem. In this first of several posts on “What Stays True for U.S. Health Care Post #Election2024,” I’ll focus on U.S. consumer dissatisfaction with drug prices — across political party identification.          Let’s set the context with data from a recently-published

 

Health Care Costs and Access On U.S. Voters’ Minds – Even If “Not on the Ballot” – Ipsos/PhRMA

Today marks eight days before #Election2024 in the U.S. While many political pundits assert that “health care is not on the ballot,” I contend it is on voters’ minds in many ways — related to the economy (the top issue in America), social equity, and even immigration (in terms of the health care workforce). In today’s Health Populi blog, I’m digging into  Access Denied: patients speak out on insurance barriers and the need for policy change, a study conducted by Ipsos on behalf of PhRMA, the Pharmaceutical Research and Manufacturers of America — the pharma industry’s advocacy organization (i.e., lobby

 

The Health Insurance Premium for a Family Averages $25,572 in 2024 – KFF’s Annual Update on Employer-Sponsored Benefits

The premium for employer-sponsored health plans grew by 6-7% between 2023 and 2024, according to the report on Employer Health Benefits 2024 Annual Survey from the Kaiser Family Foundation, KFF’s 26th annual study into U.S. companies’ spending on workers’ health care.                 In 2024 the average annual health insurance premium for family coverage is $25,572, split by 75% covered by the employer (just over $19,000) and 25% borne by the employee ($6,296), shown in the first chart from the report. The nearly $26K family premium is the average across all plan types in the

 

Americans’ Perspectives on Pharma and Healthcare Industries Are Low and Low-Ish Compared with Most Other Sectors

Only 20% of U.S. adults have a positive view of the pharmaceutical industry, garnering the lowest positive vibes among Americans in Gallup’s latest survey on peoples’ opinions of industries in America. About 1 in 3 Americans feel positively about health care in the U.S., on par with publishing and the electric/gas industries — on the lower end of these findings.             By far, the top-perceived industry in the U.S. is agriculture and farming, taking the first spot with 64% of Americans’ positive views. Restaurants and the computer sector get 52% positives, although Gallup points out

 

Obesity is a Public Health Epidemic in the U.S. — The Case for GLP-1 Coverage, Affordability and Equity

“If the U.S. were sensible, weight management would be treated as a public health issue,” David Cutler writes in the JAMA Health Forum dated August 15, 2024. Dr. Cutler, distinguished economics professor at Harvard, talks about “the pathology of U.S. health care” citing the example of weight loss medications — in short, the uptake of GLP-1 drugs to address Type 2 diabetes first, and subsequently obesity.          Dr. Cutler notes that the price of these drugs in the U.S. “far exceeds” that of other countries: specifically, 9 times that of the prices in Germany and the Netherlands

 

Where Democrats and Republicans Agree on Health Care Policies – From Medicare and Prescription Drugs to Gun Safety

In a super-divided electorate like the U.S. with about 60 days leading up to the 2024 Elections, we might assume there are no “purple” areas of agreement between the Red (Republicans) and the Blue (Democrats) thinking in PANTONE color politics. Surprisingly, there are many health policies on which Democrats and Republicans concur, as found in a series of YouGov polls conducted in May 2024.                         YouGov fielded the health policies poll in five waves online, each among roughly 1,100 U.S. adults in May 2004. This bar chart summarizes health

 

How Voting Plays Into Health, Health Equity, and Community Well-Being

“Voter registration in hospitals is the new frontier in health care.” That’s the headline in a WBUR story last week detailing the efforts of health care professionals in “amplifying” their patients’ voices inside and outside of the hospital walls by advocating for their health citizenship — through voter registration and public health policy advocacy.                  I’m a long-time evangelist for health citizenship and the role that a person’s engagement in the civic commons plays in one’s own health, the health of their communities and of the nation as a whole. I’m not alone

 

Women’s Health Outcomes in the U.S.: Spending More, Getting (Way) Less – 4 Charts from The Commonwealth Fund

Women in the U.S. have lower life expectancy, greater risks of heart disease, and more likely to face medical bills and self-rationing due to costs, we learn in the latest look into Health Care for Women: How the U.S. Compares Internationally from The Commonwealth Fund.              The Fund identified four key conclusions in this global study: Mortality, shown in the first chart which illustrates women in the U.S. having the lowest life expectancy of 80 years versus women in other high-income countries; Health status, with women in the U.S. more likely to consume multiple prescription

 

Retail Health Update for Pharmacy – Mail Order Beats Brick & Mortar, J.D. Power Finds

People have been undergoing their own human kind of digital transformations, turbocharged during the pandemic for many who never used Zoom or Amazon Prime or Uber. That consumer-borne digital transformation has shaped people as health consumers, many having used telehealth and appointment-scheduling online. And peoples’ relationships with pharmacies are also changing, with more health consumers finding greater satisfaction with their mail order pharmacy experiences than with moat retail brick and mortar chain drug stores, the latest J.D. Power 2024 U.S. Pharmacy Study found.                       It’s clear that mail order is

 

Older Americans Mostly Receptive to Apps for Health, but Chronically Ill People Could Use a Nudge (and a Payer)

AARP found that 7 in 10 people ages 50+ are “app-receptive” for health and wellness apps in Unlocking Health and Wellness Apps: Experiences of Adults Age 50-Plus, a summary of research conducted with U.S. consumers 50 and over from AARP.           The methodology for this study included only older consumers who were comfortable in downloading apps to smartphones or tablets, and were willing to do so — whom AARP considered the target audience for this research. In addition, the respondents surveyed were also at least interested in trying apps designed for health and wellness, thus dubbed “health

 

What’s Expected to Drive Up Health Plan Costs in 2025: GLP-1s, Behavioral Health, and Inflationary Pressures for Hospitals and Doctors – PwC’s Behind the Numbers 2025

The U.S. Bureau of Labor Statistics had good news for American consumers long-facing inflation for household spending over the past couple of years, announcing on July 11, 2024, that the general consumer price index (CPI) fell, lowering real prices for people buying airline tickets, used cars and trucks, communication, and petrol to fill auto tanks.               That positive economic news did not extend to medical care and personal care, the BLS reported, whose costs increased by 3.3% and 3.2%, respectively. (Motor vehicle insurance costs grew a whopping 19.5% in the report, FYI). Following the

 

Medical Debt, Aflac on Eroding Health Benefits, the CBO’s Uninsured Forecast & Who Pays for Rising Health Care Prices: A Health Consumer Financial Update

On June 11, Rohit Chopra, the Director of the Consumer Financial Protection Bureau (CFPB) announced the agency’s vision to ban Americans’ medical debt from credit reports. He called out that, “In recent years, however, medical bills became the most common collection item on credit reports. Research from the Consumer Financial Protection Bureau in 2022 showed that medical collections tradelines appeared on 43 million credit reports, and that 58 percent of bills that were in collections and on people’s credit records were medical bills.” Chopra further explained that medical debt on a consumer credit report was quite different than other kinds

 

Most Americans Follow an Eating Pattern in Search of Energy, Protein, and Well-Being – With Growing Financial Stress: A Food as Medicine Update

Most Americans follow some kind of eating regime, seeking energy, more protein, and healthy aging, according to the annual 2024 Food & Health Survey published this week by the International Food Information Council (IFIC). But a person’s household finances play a direct role in their ability to balance healthful food purchases and healthy eating, IFIC learned.              In this 19th annual fielding of this research, IFIC explored 3,000 U.S. consumers’ perspectives on diet and nutrition, trusted sources for food information, and new insights into peoples’ views on the GLP-1 weight-loss drugs and the growing sense

 

Most Americans, Both Younger and Older, Worry About the Future of Medicare and Social Security

You would assume that most people over 50 would be worried about the financial future of Medicare to cover health care as those middle-aged Americans age. But a surprising two-thirds of young Americans between 18 and 29, and 7 in 10 between 30 and 39 years of age, are concerned that Medicare’s solvency will worsen leading to their not being able to receive Medicare when eligible to receive it, discovered in the 2024 Healthcare in America Report from West Health and Gallup. This year’s research focused on aging in America, exploring areas of U.S. health care system successes as well

 

A 2025 Subaru Forester, a Year at U-New Mexico, or a Health Plan for a Family of Four: the 2024 Milliman Medical Index

Health care costs for an “average” person covered by an employer-sponsored PPO in the U.S. rose 6.7% between 2023 and 2024, according to the 2024 Milliman Medical Index. Milliman also calculated that the largest driver of cost increase in health care, accounting for nearly one-half of medical cost increases, was pharmacy, the cost of prescription drugs, which grew 13% in the year.             The big number this year is $32,066, which is the cost of that employer-sponsored PPO for a family of 4 in 2024. I’ve curated the chart of the MMI statistic for many

 

Grocers, Food Retailers and Retail Pharmacies Prioritizing Wellness and Health in 2024

Thanks to Progressive Grocer’s 91st annual report and research therein, we have fresh insights into where wellness and nutrition fit into food retailers’ — and pharmacies’ and Big Box stores’ — strategies. That priority ranks high in grocers’ plans for in-store services in 2024 and beyond.               Far above all other strategies for food retailers’ in-store services, we see that on-site butchers rank high — among 3 in 4 retailers. Why this might be the case: cost- and value-focused consumers often have questions about how to cook different (lower-priced) costs of meat, or desire

 

Prescriptions Are Up, Health Services Utilization Down, and GLP-1s Are a Major Growth Driver: IQVIA’s 2024 Update

In the past year, the growth of prescription drug utilization and spending has much to do with the use of GLP-1 agonists to treat diabetes and obesity, along with immunology therapy, and lipid meds, along with specialty medicines now accounting for over half of spending — up from 49% in 2018. This update comes from The Use of Medicines in the U.S. 2024 from the IQVIA Institute for Human Data Science. The annual report details trends in health services utilization, the use of prescription drugs, patient financing of those costs, the drivers underpinning the medicines spending, and an outlook to 2028.

 

The Cost of Medical Care, Long-Term Care, and Prescription Drugs Top Older Americans’ Health-Related Concerns – With Social Security and Medicare Top of Mind

Among Americans 50 years of age and over, the top health-related concerns are Cost, Cost, and Cost — for medical services, for long-term and home care, and for prescription medications. Quality of care ranks lower as a concern versus the financial aspects of health care in America among people 50 years of age and older, as we learn what’s On Their Minds: Older Adults’ Top Health-Related Concerns from the University of Michigan Institute for Healthcare Policy and Innovation. AARP sponsors this study, which is published nearly every month of the year on the Michigan Medicine portal.           

 

Healthcare 2030: Are We Consumers, CEOs, Health Citizens, or Castaways? 4 Scenarios On the Future of Health Care and Who We Are – Part 1

In the past few years, what event or innovation has had the metaphorical impact of hitting you upside the head and disrupted your best-laid plans in health care? A few such forces for me have been the COVID-19 pandemic, the emergence of Chat-GPT, and Russia’s invasion of Ukraine. That’s just three, and to be sure, there are several others that have compelled me to shift my mind-set about what I thought I knew-I-knew for my work with organizations spanning the health care ecosystem. I’m a long-time practitioner of scenario planning, thanks to the early education at the side of Ian

 

Considering Equity and Consumer Impacts of GLP-1 Drugs – A UBS Economist Weighs In

Since the introduction of GLP-1 drugs on the market, their use has split into two categories: for obesity and “recreationally,” according to the Chief Economist with UBS (formerly known as Union Bank of Switzerland). Paul Donovan, said economist, discusses The economics of getting thin in his regularly published comment blog.                   “These different uses have different economic consequences,” Donovan explains: Obese patients who use GLP-1s should become more productive employees, Donovan expects — less subject to prejudice, and less likely to be absent from work. While so-called recreational GLP-1 consumers may experience these

 

The Self-Prescribing Consumer: DIY Comes to Prescriptions via GLP-1s, the OPill, and Dexcom’s CGM

Three major milestones marked March 2024 which compel us to note the growing role of patients-as-consumers — especially for self-prescribing medicines and medical devices. This wave of self-prescribed healthcare is characterized by three innovations: the Opill, GLP-1 receptor agonists, and Dexcom’s Continuous Glucose Monitoring (CGM) system that’s now available without a prescription. Together, these products reflect a shift in health care empowerment toward patients as consumers with greater autonomy over their health care when the products and services are accessible, affordable, and designed with the end-user central to the value proposition and care flows. Let’s take a look at each

 

The Women’s Health Gap Is Especially Wide During Her Working Years – Learning from McKinsey, the World Economic Forum, and AARP in Women’s History Month

There’s a gender-health gap that hits women particularly hard when she is of working age — negatively impacting her own physical and financial health, along with that of the community and nation in which she lives.               March being Women’s History Month, we’ve got a treasure-trove of reports to review — including several focusing on health. I’ll dive into two for this post, to focus in on the women’s health gap that’s especially wide during her working years. The reports cover research from the McKinsey Health Institute collaborating with the World Economic Forum on

 

Americans Come Together in Worries About Medical Bills, the Cost of Health Care, and Prescription Drug Costs

In the U.S., national news media, Federal statistics, dozens of business leaders  and the Federal Reserve Bank have been talking about an historically positive American economy on a macro level. But among individual residents of the U.S., there is still a negative feeling about the economy in a personal context, revealed in the Kaiser Family Foundation Health Tracking Poll for February 2024.                I’ve selected three figures of data from the KFF’s Poll which make the point that in peoples’ negative feelings about the national economy, their personal feelings about medical costs rank high

 

People With Medical Debt Are Much More Likely to Be in Financial Distress in America

How financially vulnerable are people with medical debt in the U.S.? Significantly more, statistically speaking, we learn from the latest survey data revealed by the National Financial Capabilities Study (NFCS) from the FINRA Foundation. The Kaiser Family Foundation and Peterson Center on Healthcare analyzed the NFCS data through a consumer health care financial lens with a focus on medical debt.          Financial distress takes many forms, the first chart inventories. People with medical debt were most likely lack saving for a “rainy day” fund, feel they’re “just getting by” financially, feel their finances control their life, and

 

Nurses Earn Highest Grade for Care Far Above All Other Health Care Workers — Including Doctors — In Latest Gallup Poll

Nurses rank highest among various factors in the U.S. health system in the latest Gallup poll — earning a grade of “excellent” or “good” by American adults surveyed in November 2023.               Further substantiation for nurses’ topping this poll of excellent care is that Gallup found historic low confidence in the U.S. health system among Americans  earlier this year in a July study. Note that 8 in 10 consumers rate nurses excellent/good compared with  7 in 10 people ranking physicians this way, 6 in 10 for hospitals, 5 in 10 for telemedicine/virtual visits, and

 

Inflation and the cost of health care top U.S. voters’ issues for 2024 elections

The cost of living ranks top in U.S. voters’ minds among many issues Americans are feeling and following in late 2023. A close second in line is affordability of health care, as consumers’ household budgets must make room for paying medical bills — with prescription drug costs also very important as a discussion topic for 2024 Presidential candidates, we learn from the latest KFF Health Tracking Poll published 1 December. The monthly study focused on U.S. voters’ top issues and perspectives on the health system and care approaching the new year of 2024. KFF fielded the study among 1,301 U.S.

 

Healthcare Bills, Affordability, and Self-Rationing Care Will Continue to Challenge U.S. Health Consumers in 2024

Two-thirds of U.S. consumers say they can’t afford to pay their medical bills on-time, based on the 2023 Consumer Survey from Access One, a financial services company focused on healthcare payments.               The report’s title page asks the question, “What options do consumers really want for paying healthcare expenses?” The survey report responds to that question, finding out that nearly one-half of patients have taken some kind of action to reduce their medical expenses. Furthermore, one-third of consumers are not confident they could pay a medical bill of $500 or more. Access One fielded

 

“My Doctor’s Office” Should Accept Wearable Tech Health Data, Most Patients Say

“Do personal health trackers belong in the doctor’s office?” Software Advice wondered. “Yes,” the company’s latest consumer survey found, details of which are discussed in a report published on their website. Unique to this study is the patient sample polled: Software Advice surveyed 876 patients in September 2023 to gauge their perspectives on wearable tech and health. Note that the patient sample was limited to consumers who had seen a health care provider in the past two years and who also owned and used a personal wearable health device such as an Apple Watch or Fitbit. Thus, the responses shared

 

What Walmart’s Look at Ozempic Users Tells Us About Health/Care Consumers

“We definitely do see a slight change compared to the total population, we do see a slight pullback in overall basket,” the CEO of Walmart US is quoted in Bloomberg. “Just less units, slightly less calories.”                   With patients’ use  GLP-1 drugs such as Ozempic, Wegovy, and Mounjaro fast-rising in the pharmacy market, so are the concerns of companies that stock the-middle-of-the-grocery-store aisles for processed foods like sweet and salty snacks. As the prospects for the drug companies who manufacture prescription drugs made for patients managing diabetes and obesity are on the

 

Food-As-Medicine Grows Its Cred Across the Health/Care and Retail Ecosystem

In the nation’s search for spending smarter on health care, the U.S. could save at least $13 billion a year through deploying medically-tailored meals for people enrolled in Medicare, Medicaid, and private insurance programs, according to the True Cost of Food, research published by the Tufts School of Nutrition Science and Policy collaborating with The Rockefeller Foundation.       It’s been one year since the White House convened the Conference on Hunger, Nutrition, and Health, kicking off the Biden Administration’s national strategy to improve health citizens’ access to healthy food as a matter of public health and economic security.

 

Slip Slidin’ Away: the Reputations of Pharma and Healthcare in the U.S. Decline in the Latest Gallup Poll

Oh, how quickly people forget…and slow to forgive. U.S. consumers’ positive views for healthcare, pharma and retail have significantly fallen in just one year, the latest annual Gallup poll of industry rankings in America found as of August 2023. This stat for the pharma industry was the lowest Gallup ever recorded for the sector since 2001.                     I can’t help hearing Paul Simon’s lyrics to Slip Slidin’ Away….”you know the nearer your destination, the more you’re slip slidin’ away” when it comes to health citizens’ perceptions of pharma and the healthcare

 

Hims and Hers and Hearts – Cardiology Blurs Into DTC Retail Health

Statin therapy has been used for decades to lower cholesterol with the goal of reducing mortality and preventing cardiovascular problems such as heart attacks and strokes. Hims & Hers announced a new service offering for health consumers and clinicians concerned about heart health called Heart Health by Hims.               This is Hims & Hers’ first foray into cardiovascular health, working in collaboration with the American College of Cardiology (ACC). ACC clinical guidelines will inform the Hims’ provider platform for the program. “Prevention is the ideal mechanism to decrease cardiovascular events and ensure optimal heart

 

The Doctor Will See You Now…At Home? The AMA Launches a Health at Home Framework

An aging U.S. population with a preference for growing older at home — and a fiscally challenging health care financing outlook — are setting the demographic and financial table for the shift of medical care to peoples’ homes discussed in The State of Health at Home Models: Key Considerations and Opportunities, published by the American Medical Association (AMA).             Note that this framework has been developed by the AMA, the largest professional organization of doctors. While moving health care to the home will involve quite different workflows and disruptions to current general medical practice, it

 

Pharmacy Plays a Growing Role in Consumers’ Health@Retail – J.D. Power’s 2023 Rankings

“Brick-and-mortar pharmacies forge meaningful connections with customers” through conversations between pharmacists and patients, “on a first-name basis.” This quote comes from Christopher Lis, managing director of global healthcare intelligence at J.D. Power who released the company’s annual 2023 U.S. Pharmacy Study today, the 15th year the research has been conducted.                           Each year, J.D. Power gauges U.S. consumers’ views on retail pharmacies in four channels: brick and mortar chain drug stores, brick and mortar mass merchandisers, brick and mortar supermarkets, and mail order. Across all four channels, the

 

Cost Trumps Quality of Health Care for Consumers As Their Experience Has Eroded

Patients’ perceptions of health care quality and experience have fallen in the three years since 2020, based on a July 2023 update from The Beryl Institute – Ipsos Px Pulse study.         Start with health care quality, which 58% of U.S. adult patients ranked as “very good or good” in June 2020. The percent of health consumers evaluating their healthcare quality as very good or good fell to 41% of people in June 2023, an erosion of 17 percentage points, shown in the first chart.         Next, consider patients’ ratings on their care experience,

 

GNC Offers “Free Healthcare” — Telehealth, Generic Meds, and Loyalty in the Retail Health Ecosystem

The retail health landscape continues to grow, now with GNC Health offering a new program featuring telehealth and  “curated set” of 40+ generic prescription drugs commonly used in urgent care settings.             The services are available to members of GNC’s new-and-improved loyalty program, GNC PRO Access, which is priced at a fixed fee of $39.99 for one year’s membership. This is available to consumers 18 years of age and older. “As a trusted brand in the health and wellness space, we are thrilled to expand our efforts in helping our customers Live Well by offering

 

To Avert a GLP-1 Cost Tsunami, Add Lifestyle Interventions: Learning from Virta Health

With consumer and prescriber interest in GLP-1 receptor agonist drugs “soaring,” health plan managers have a new source of financial stress and clinical questions on their to-do list. A team of Virta Health leaders held a webinar on 13th July 2023 to explain the results of a study the company just completed assessing health plan execs’ current views on Ozempic and other GLP-1 medicines with a view on both clinical outcomes and cost implications for this growing category of drugs that address diabetes and obesity.             Indeed, diabetes and obesity are top health concerns among the

 

There’s a New “O” in Medicine-Town – Welcome OPill to the Front of the Counter

You may not be able to get that ear-worm jingle that goes “O O O Ozempic” out of your musical mind, but I’m happy to tell you there’s a new “O” in town: the Opill. Welcome to the first OTC contraceptive for sale in the USA.                     I wrote about Perrigo’s Opill here in Health Populi in May 2023 as a “signpost on the road to retail health.” It’s official: “The U.S. Food and Drug Administration (FDA) approved Opill®, a progestin-only daily oral contraceptive, for over-the-counter (OTC) use for all ages.

 

The Cost of Treating Patients is On the Rise: PwC Goes What’s Behind the 2024 Medical Spending Numbers

Health care cost trend will spike up another percentage point to 7.0% in 2024, according to the annual report from the PwC Health Research Institute, Medical cost trend: Behind the numbers 2024.                 Every year, the PwC HRI team goes behind those numbers to assess cost inflators and deflators which underpin annual medical inflation. As the first line chart illustrates, the peak of medical trend in the last 18 years was in 2007 when the U.S. saw double-digit cost growth of nearly 12%. Here’s a link to PwC’s 2007 study looking behind the

 

The Latest KFF Poll on Consumer Experiences with Health Insurance Speaks Volumes About Patients’ Administrative Burden

People love being health-insured, but their negative experiences with health plans create serious burdens on patients-as-consumers. And those burdens impact even more people who are unwell than healthier folks. The 2023 Kaiser Family Foundation Survey of Consumer Experiences with Health Insurance updates our understanding of and empathy for insured peoples’ Patient Administrative Burdens (PAB). For this study, KFF polled 3,605 U.S. adults 18 and over in February and March 2023 who had health insurance across different plan types. Over the past several years, I’ve come to appreciate the concept of PAB by listening to and learning from colleagues Dr, Grace

 

Patients-As-Health Care Payers Define What a Digital Front Door Looks Like

In health care, one of the “gifts” inspired by the coronavirus pandemic was the industry’s fast-pivot and adoption of digital health tools — especially telehealth and more generally the so-called “digital front doors” enabling patients to access medical services and personal work-flows for their care. Two years later, Experian provides a look into The State of Patient Access: 2023.                     You may know the name Experian as one of the largest credit rating agencies for consumer finance in the U.S. You may not know that the company has a significant footprint

 

Consumers and Cancer: 3 Patient-Focused Charts From IQVIA on the State of the Oncology in 2023 – and Introducing CancerX

It’s time for the annual ASCO conference, currently convening the American Society for Clinical Oncology in Chicago. Starting 2nd June, there have been dozens of positive announcements updating research and therapies bringing hope to the 2 million new patients who will be diagnosed with cancer in the U.S. in 2023, and millions of more people worldwide. Just in time for #ASCO2023, the IQVIA Institute published their annual report on Global Oncology Trends 2023 – Outlook to 2027, an update featuring pipelines, therapy approvals, research updates, costs of oncology products, and patients.                  

 

Our Mental and Emotional Health Are Interwoven With What We Eat and Drink – Chewing On the IFIC 2023 Food and Health Survey

As most Americans confess to feeling stressed over the past six months, peoples’ food and beverage choices have been intimately connected with their mental and emotional well-being, we learn from the 2023 Food & Health Survey from the International Food Information Council (IFIC). For this year’s study, IFIC commissioned Greenwald Research to conduct 1,022 interviews with adults between 18 and 80 years of age in April 2023. The research explored consumers’ perspectives on healthy food, the cost of food, approaches to self-care through food consumption, the growing role of social media in the food system, and the influence of sustainability

 

Getting Health Care at a Retail Pharmacy vs a Retail Store: Consumers May Be Favoring the Pharmacist Versus the Retailer

Not all “retail health” sites are created equal, U.S. consumers seem to be saying in a new study from Wolters Kluwer Health, the company’s second Pharmacy Next: Consumer Care and Cost Trends survey. Specifically, consumers have begun to differentiate between health care delivered at a retail pharmacy versus care offered at a retail store — such as Target or Walmart (both named as sites that offer “health clinics in department stores” in the study press release). While 58% of Americans were likely to visit a local pharmacy as a “first step” when faced with a non-emergency medical situation and 79%

 

Three More Signposts on the Road to Retail Health – Weight Loss Drugs, OTC Birth Control and Fashion-Meets-the-Flu

We continue to track to evolving, expanding landscape of retail health — which we see as the expanding ecosystem of health/care accessible to people-as-health consumers. This week, three intriguing examples are resonating with us: The ever-evolving weight-loss industry FDA favors OTC use for Perrigo’s Opill daily oral contraceptive birth control pill The convergence of fashion and health — specifically, how an over-the-counter medicine converges with clothing that helps us feel better.                   Let’s start with weight-loss, as several aspects of health/care come together in the consumer’s retail health sandbox. Dr. Eric Topol

 

Thinking Pharma on a Friday: Europe’s Big Reforms for a Health Union & the U.S. 50-State Fragments

The COVID-19 pandemic re-shaped European Union leaders to reimagine healthcare, public health, and health citizenship in the EU. Welcome to #HealthUnion, the hashtag that the European Commission has adopted with the vision of assuring access to medicines for all people living in the 27-nation EU area — regardless of socioeconomic status.             On 26th April 2023, the EC unveiled the most significant reforms for the region’s pharmaceutical industry in twenty years. It’s really a package or “toolkit” in the words of EC Health and Food Safety Commissioner Stella Kyriakides for addressing several strategic health pillars

 

The Patient Is Still the Payor – And May Skip Paying for Prevention (Eyes on the ACA & Texas)

Many health citizens in the U.S. would likely skip receiving preventive health care services if the Affordable Care Act’s (ACA) coverage for them goes away, a Morning Consult survey found.                   The first chart illustrates the top-line of this research: that most U.S. adults would not pay out of pocket for several preventive services including tobacco cessation, drug use screening, weight loss measures to prevent obesity-related illnesses, as well as screening for depression or HIV. One of the key benefits embedded in the ACA was “free” without co-pay shares for  preventive care. These

 

People Using Health Apps and Wearable Tech Most Likely Track Exercise and Heart Rate, Sleep and Weight – But Cost Is Still A Barrier

Over one in three U.S. consumers use a health app or wearable technology device to track some aspect of their health. “The public’s use of health apps and wearables has increased in recent years but digital health still has room to grow,” a new poll from Morning Consult asserts, published today.                   Among digital health tech users, most check into them at least once every day in the past month. One in four use these tech’s multiple times a day, the first pie chart illustrates. Eighteen percent of people use their digital

 

Quick, Accessible, Inexpensive Health Care – A Retail Health Update from Amazon and Dollar General

Two announcements this week add important initiatives to patients’ growing choices that speak to their consumer-sides’ sense of value and personal healthcare cost-containment: Amazon launched RxPass, a generic medicines subscription service; and, Dollar General promoted its mobile health service powered by DocGo on demand for health visits, “right outside the store.”             These two programs come from outside of the legacy health care system of so-called incumbents — hospitals, health systems, health insurance — leveraging two brand-names beloved to many consumers for convenience, price transparency, and sheer cost. First, check out Amazon Pharmacy’s RxPass. Amazon

 

When Household Economics Blur with Health, Technology and Trust – Health Populi’s 2023 TrendCast

By Jane Sarasohn-Kahn on 22 December 2022 in Anxiety, Behavioral health, Big data and health, Big Tech, Broadband, Business and health, Cardiovascular health, Chronic care, Chronic disease, Connected health, Consumer electronics, Consumer experience, Consumer-directed health, Coronavirus, COVID-19, Cybersecurity, Data analytics and health, Demographics and health, Depression, Design and health, Determinants of health, Diet and health, Digital health, Employee benefits, Employers, Financial health, Financial wellness, Fitness, Food and health, Grocery stores, Health apps, Health at home, Health benefits, Health care industry, Health citizenship, Health Consumers, Health costs, Health disparities, Health Economics, Health ecosystem, Health engagement, Health equity, Health insurance, Health Plans, Health policy, Health politics, Health privacy, Healthcare DIY, Heart disease, Heart health, HIPAA, Home care, Home economics, Home health, Hospitals, Infectious disease, Love and health, Medication adherence, Meditation, Mental health, Mindfulness, Moms and health, Money and health, Out of pocket costs, Patient experience, Personal health finance, Pharmaceutical, Pharmacy, Physicians, Popular culture and health, Prescription drugs, Prevention and wellness, Primary care, Public health, Race and health, Remote health monitoring, Retail health, Risk management, SDoH, Self-care, Shopping and health, Social determinants of health, Specialty drugs, Stress, Telehealth, Telemedicine, Transparency, Trust, User experience UX, Vaccines, Value based health, Virtual health, Vitamins, Wearable tech, Wellbeing, Workplace benefits

People are sick of being sick, the New York Times tells us. “Which virus is it?” the title of the article updating the winter 2022-23 sick-season asked. Entering 2023, U.S. health citizens face physical, financial, and mental health challenges of a syndemic, inflation, and stress – all of which will shape peoples’ demand side for health care and digital technology, and a supply side of providers challenged by tech-enabled organizations with design and data chops. Start with pandemic ennui The universal state of well-being among us mere humans is pandemic ennui: call it languishing (as opposed to flourishing), burnout, or

 

Consumers Are Feeling Their Healthcare Cost of Living – Research from Qualtrics

Rising costs are the #1 reason U.S. health consumers are avoiding or delaying health care, replacing concerns about COVID-19, based on survey research from Qualtrics.         The company’s Healthcare Cost of Living survey research learned that 48% of U.S. adults chose to defer health care in 2022, split by 31% of consumers skipping care due to cost concerns, and, 17% of people delaying care who had concerns about the coronavirus. Note the types of care delayed or skipped: Over 27% of people delayed care related to nutrition 26% delayed routine or preventive care, such as screenings or

 

Consumers Rank Healthcare Experiences in the Bottom-Third of All Industries – the ACSI 2021-2022 Index

While consumers’ satisfaction with inpatient care experiences improved a few points over the past year, health insurance and hospitals still fall in the bottom-third of all industries with which people interact, according to the American Customer Satisfaction Index (ACSI) Insurance and Health Care Study 2021-2022.               “With visitor restrictions relaxing and more elective procedures going forward, hospitals are slowly coming out of a COVID-induced satisfaction slump,” the study press released quoted Forrest Morgeson, Assistant Professor of Marketing at Michigan State University. This year’s ACSI Insurance and Health Care Index was developed through 12,840 consumer interviews

 

$22,463 Can Get You a Year of College in Connecticut, a Round of Ref Work in the Stanley Cup Playoffs, or Health Benefits for a Worker’s Family

Employers covering health insurance for workers’ families will face insurance premiums reaching, on average, $22,463. That is roughly what a year at an independent college in Connecticut would cost, or a round of pay for a ref in the Stanley Cup playoffs. With that sticker-shock level of health plan costs, welcome to the 2022 Employer Health Benefits Survey from Kaiser Family Foundation, KFF’s annual study of employer-sponsored health care.                 Each year, KFF assembles data we use all year long for strategic and tactical planning in U.S. health care. This mega-study looks at

 

Consumers’ Trust In Pharmacists As Providers Grows Along with Omnichannel Health Care

What is a “pharmacy” these days? You might have recently walked into a brick-and-mortar retail pharmacy. Or, you might have refilled a prescription to help you manage a chronic condition, online. Or, perhaps, you asked the pharmacist staffing your favorite grocery store Rx counter to give you the latest vaccine to keep COVID-19 variants at-bay. The pharmacy is all these things, and increasingly digital-first, we learn in The Rx Report: A new day in retail pharmacy, a consumer survey from CVS Health.         CVS Health, one of the two largest pharmacies operating in the U.S. in 2021

 

How Will the “New” Health Economy Fare in a Macro-Economic Downturn?

What happens to a health care ecosystem when the volume of patients and revenues they generate decline? Add to that scenario a growing consensus for a likely recession in 2023. How would that further impact the micro-economy of health care?                   A report from Trilliant on the 2022 Trends Shaping the Health Economy helps to inform our response to that question. Start with Sanjula Jain’s bottom-line: that every health care stakeholder will be impacted by reduced yield. That’s the fewer patients, less revenue prediction, based on Trilliant’s 13 trends re-shaping the U.S. health

 

Health in the 2022 U.S. Midterm Elections – Women, Prescription Drugs, and Who Shows Up to Vote

On Tuesday November 8, 2022, health and medical issues will be on many U.S. voters’ minds as they enter voting booths to select representatives for the House and the Senate, along with some states’ ballots addressing specific healthcare issues. Health policy experts from Manatt, Phelps & Phillips, AARP, and the United States of Care recently shared perspectives on the health care issues on voters’ and policy makers’ minds for the 2022 midterm elections. This post synthesizes their analyses as we lead up to what will be a pivotal election for Americans’ public health, individual well-being, and access to care.  

 

The Patient as Prescription Drug Payer – The GoodRx Playbook

Patients have more financial skin-in-their-healthcare-games facing high-deductibles and direct out-of-pocket costs for medical bills…including prescription drugs. I collaborated with GoodRx on a “yellow paper” discussing The Health Consumers as Payer, with implications and calls-to-action for pharma and life science companies. You can download the paper at this link.               The report is intended to be a playbook for understanding patients’ growing role as consumers and health care payers, providing insights into peoples’ home economic mindsets and how these impact a patient’s adherence to medication based on cost and perceived value. With inflation facing household

 

Telehealth-As-Healthcare Is a Mainstream Expectation Among Consumers, J.D. Power Finds

Telehealth has increased access to mental health services, I’ve highlighted this Mental Illness Awareness Week here in Health Populi. But telehealth has also emerged as a preferred channel for routine health care services, we learn from J.D. Power’s 2022 Telehealth Satisfaction Study.           Among people who had used virtual care in the past year, telehealth-as-healthcare is now part of mainstream Americans’ expectations as a normal part of their medical care. That’s because 9 in 10 users of telehealth in the U.S. would use virtual care to receive medical services in the future, J.D. Power found in

 

Remember the Social Determinants of Health When Prescribing Drugs

Thinking about the social determinants of prescription drugs, how people take medicines in real life in my latest post in Medecision’s Liberate Health blog.           I had one of those special lightbulb moments when listening to Mauricio Gonzalez-Arias, M.D. of NYC Health + Hospitals and Suvida Healthcare discussing medication adherence and what prevents us from taking our meds as prescribed. His discussion on social determinants’ role in shaping our relationship with prescriptions was powerful, and the jumping off point for this essay.           Medication adherence is a challenge that fiscally costs the

 

Gallup Reveals Americans’ Views on Industry Are the Lowest Since 2008 – Implications for Healthcare and Pharma

Americans’ positive views of 25 industries in the U.S. have declined in the past year. In their latest look into consumers’ views on business in America, Gallup found that peoples’ ratings on business fell to their lowest ratings overall since 2008.           Peoples’ highest ratings of industry in American occurred in 2017 when nearly 50% of people gave business a very or somewhat positive grade. The year-on-year decline from 2021 find oil and gas at the lowest level of positivity, advertising/PR, legal, the Federal government, and pharma at the bottom of the ratings.      

 

As Walmart Allies with LLENA (AI), Food-as-Medicine Blurs with Digital Health Tech and Equity

In a busy week of news in the health care and digital health world, it would be easy to miss a press release published on 23rd August on the food-as-medicine front. But don’t blink this snippet away. It is another strong signal about the growing blur between grocery stores, food, digital tech, and population health.       The digital health platform LLENA (AI) announced its collaboration with Walmart to support people managing diabetes with personalized nutrition support from data tracking pulling through to healthy food delivery. Note LLENA (AI)’s tagline: “where AI meets GI for better health.” “LLENA” is

 

Partnering Up in the Health Care Ecosystem to Drive Transformation – for Organizations and Health Consumers Alike

“Partnerships, including JVs and alliances with other healthcare organizations and with new entrants, are just one way to access new capabilities, unlock speed to market, and achieve capital, scale, and operational efficiencies” in health care transformations. “In an environment with continued competition for attractive assets and significant capital in play from institutional investors, these partnerships may also be the most accessible way for organizations to capture value in expanding healthcare services and technology value pools,” we learn in Overcoming the cost of healthcare transformation through partnerships from a team of health care folks with McKinsey & Company.      

 

Americans Rationing Healthcare in the Inflationary Era; Out-of-Pocket Expenses Are the Concern

Nearly 100 million people in the U.S. cut back on healthcare due to costs in the first half of 2022, according to the latest poll on health care costs form Gallup and West Health, gauging Americans’ financial health in June 2022. That’s the month when inflation in the U.S. reached 9.1%, a 40-year high.             Among Americans’ cuts to household spending was the most common medical self-rationing behavior, delaying or avoiding  care or purchasing prescription drugs, the survey found. Nearly 4 in 5 people in the U.S. had delayed care or prescription meds between January

 

Patient Support Isn’t Just About the Price of Therapy: It’s About Safety, Really Rich Data and Trust

When I talk about patient support programs (PSPs), I’m most often focused on supporting peoples’ access to medicines due to costs, bolstering health literacy, and addressing health citizens’ risks of drivers of health that can be obstacles to optimal health outcomes (those challenging social determinants of health). A new report from Deloitte on Intelligent post-launch patient support speaks to another crucial definition of patient support: post-market surveillance and patient safety.                 The paper’s central thesis is that improving patient support is a critical step in the biopharma value chain, illustrated in the first diagram

 

The Retail Health Battle Royale in the U.S. – A Week-Long Brainstorm, Day 2 of 5 – Amazon and One Medical

Today we review the various viewpoints on Amazon’s announced acquisition of One Medical (ONEM, aka 1life Healthcare) which has been a huge story in both health care trade publications, business news, and mainstream media outlets. Welcome to Day 2 of The Retail Health Battle Royale in the U.S., my week-long update of the American retail health/care ecosystem weaving the latest updates from the market and implications and import for health care consumers.       The deal was announced on 21 July, with Amazon striking the price at about $3.9 billion. Goldman Sachs and Morgan Stanley put the deal together,

 

The Old Gays Working with Walgreens on TikTok: Breaking Down Stereotypes and Having Fun with Health

How much do I love this media campaign from Walgreens, collaborating with the foursome The Old Gays who have a growing multi-million person fan base on TikTok? How much? A whole lot! Kudos to Walgreens for creating engaging, informative, and fun! content to learn about how people can benefit from using the company’s app ….for, Ordering prescriptions (90-day supply) Receiving delivery same-day 24/7 pharmacy chat on pricing, prescription drug information, and medications. The plotline kicks off with 3 of the 4 quartet (Jessay Martin, Robert Reeves and Mick Peterson) looking for their friend Bill Lyons, who is missing from their

 

Gas ‘N Healthcare – How Transportation Links to Health Care Access and Financial Health

Some patients dealing with cancer at Mercy Health’s Lourdes Hospital have been supplied with gas cards. This gesture is enabling families to get to medical appointments around Paducah, Kentucky where, this week, car drivers faced regular gas priced at an average of $4.16 a gallon compared with $2.92 one year ago.           Here’s the Hospital’s Facebook page featuring their gratitude to FiveStar Food Mart, the American Cancer Society, and the Mercy Health Foundation. “By providing cancer patients with gas cards, the cancer care team at Mercy Health Lourdes Hospital in Paducah hopes to mitigate financial challenges

 

In A Declining Consumer Tech Spending Forecast, Consumer Health Tech Will Grow in 2022: Reading the CTA Tea Leaves

Supply chain challenges, inflation, and plummeting consumer economic sentiment are setting the stage for a decline in consumer electronics revenues for 2022. However, there will be some bright spots of growth for consumer tech spending, for 5G smartphones, smart home applications, gaming, and health technologies, noted in the Consumer Technology Association’s CTA U.S. Consumer Technology One-Year Industry Forecast, 2018-2023.             Underneath the overall industry spend of $503 billion, a 0.2% drop from 2021, CTA expects software, gaming, video and audio streaming spending will grow by 3.5% and hardware to fall by 1.4% this year. With

 

The Unbearable Heaviness of Inflation: Will Consumers’ Financial Stress Erode Their Health?

“Inflation is the big story,” the economics team at Morning Consult told us yesterday in a call on “How to Think Like An Economist.” While I already thought I did that, Team @MorningConsult updated us on the current state of consumers and what’s weighing most heavily on their minds…inflation being #1. An hour after the Morning Consult session, I brainstormed the topic of consumers-as-payers of medical bills and prescription drugs with GoodRx strategy leaders. In my data wonkiness, inflation certainly played a starring role in setting the stage for Mind, Body and Wallet — the title of one of the sources

 

Only in America: Medical Debt Is Most Peoples’ Problem, KHN and NPR Report

When high-deductible health plans became part of health insurance design in America, they were lauded as giving patients “more skin in the game” of health care payments. The theory behind consumer-directed care was that patients-as-consumers would shop around for care, morph into rational consumers of medical services just as they would do purchasing autos or washing machines, and shift the cost-curve of American health care ever downward. That skin-in-the-game has been a risk factor for .some patients to postpone care as well as take on medical debt — the strongest predictor of which is dealing with multiple chronic conditions. “The

 

We Are Stuck On Band-Aids, Hygiene, and Self-Care: Morning Consult’s Most Trusted Brands 2022

We are stuck on Band-Aids and hooked on hygiene and self-care according to the Most Trusted Brands 2022 study from Morning Consult.             In 2022, the most trusted brands in the United States were Band-Aid Lysol Clorox UPS CVS Health (pharmacy) VISA Cheerios The Weather Channel Colgate, and Home Depot. These products and companies sustain trends I tracked in Years 1 and 2 of the COVID-19 pandemic when several of these were most-trusted, bolstering peoples’ lives living in, working from, and making health at home.             Four key trends underscore

 

The Evolution of a Patient Ambassador – Learning from Stacy Hurt

“I am a health care executive who happens to be a patient, caregiver, and advocate,” Stacy Hurt explained to me in a Zoom chat we shared on 31 May. I asked her to meet with me to discuss her professional news update: being appointed Parexel’s first Patient Ambassador.                       My Zoom invitation to Stacy was a very convenient excuse for me to catch up with a friend in the field: we have known each other since Stacy started to grow her health-social media presence on Twitter. And that involvement in

 

What If Costco Designed the Prescription Drugs Sales Model?

The good news about prescription drugs, in the context of medical spending in the U.S., is that 9 in 10 medicines prescribed are generics. They comprise only 3% of all U.S. healthcare spending.           But there’s bad news about prescription drugs in the context of medical spending in America. U.S. Consumers Overpay for Generic Drugs, a new paper from the Leonard Schaeffer Center for Health Policy & Economics asserts, with recommendations to address the intermediaries who benefit from the way Americans currently pay for medicines. Generics are “an American success story,” the authors call out, bringing

 

A New Chevy Equinox SUV, a Year in Grad School, or Health Care for Four – The 2022 Milliman Medical Index

A new Chevy Equinox SUV, a year in an MS program in kinesiology at Pacific Lutheran U., or health care for a family of four. At $30,260, you could pick one of these three options.             Welcome to this year’s 2022 Milliman Medical Index, which annually calculates the health care costs for a median family of 4 in the U.S. I perennially select two alternative purchases for you to consider aligning with the MMI medical index. I have often picked a new car at list price and a year’s tuition at a U.S. institution of

 

Patients Look Beyond the Pandemic to Pharma for Engagement, Innovation, and Integrity

The COVID-19 pandemic has impacted patients who were already deeply engaged with their own health care before the coronavirus emerged. Compared with a year ago, more patients and their advocates are seeking quality therapies, innovation, engagement, and integrity from pharmaceutical companies, based on research published today from PatientView. PatientView, based in the UK, has collaborated with over 40,000 patient advocacy organizations globally marking over 10 years doing this research. The eleventh annual report on the Corporate Reputation of Pharma was conducted among 2,150 patient groups between November 2021 and February 2022, covering health citizens in Europe (with 1,229 organizations), North

 

How the Pandemic, Inflation and Ukraine Are Re-Shaping Health Consumers – Learnings from dunnhumby

Too many dollars, stimulated by an influx of COVID-19 government stimulus, are chasing too few goods in economies around the world. Couple this will labor, material shortages, and disrupted supply chains, the exogenous shock of the Ukraine crisis amplifying cost increases and shortage driving higher prices for food and commodities, and global consumers are faced with strains in household budgets. This is impacting grocery stores and. through my lens, will impact health consumers’ spending, as well. In their discussion of Customer First Retailer Responses to Inflationary Times, dunnhumby, retail industry strategists, covered an update on inflation with the top-line that

 

In the New Inflationary Era, Gas and Health Care Costs Top Household Budget Concerns

Inflation and rising prices are the biggest problem facing America, most people told the Kaiser Family Foundation March 2022 Health Tracking Poll. Underpinning that household budget concern are gas and health care costs. Overall, 55% of people in the U.S. pointed to inflation as the top challenge the nation faces (ranging from 46% of Democrats to 70% of Republicans). Second most challenging problem facing the U.S. was Russia’s invasion into Ukraine, noted by 18% of people — from 14% of Republicans up to 23% of Democrats. The COVID-19 pandemic has fallen far down Americans’ concerns list tied third place with

 

Can a Food-As-Medicine App Extend Chronic Health Management at the Grocery Store?

Foogal, a recipe app designed to support patients’ healthy cooking and eating, launched on 24th March. In its initial version, Foogal addresses several specific diet paradigms: for patients demanding a wellness protocol, an autoimmune protocol, or wanting to address insulin resistance. Foogal got my attention via a tweet @FoogalApp on 25th March. The snippet featured a photo of a delectable Salad Lyonnaise, one of my favorite things to eat, which adds a soft-cooked egg and bacon lardons to the greens for an easy light (and delicious!) meal. Foogal was developed by Todd Knobel, who has worked in law, in plastics,

 

The Financial Toxicity of Health Care Costs: From Cancer to FICO Scores

The financial toxicity of health care costs in the U.S. takes center stage in Health Populi this week as several events converge to highlight medical debt as a unique feature in American health care. “Medical debt is the most common collection tradeline reported on consumer credit records,” the Consumer Financial Protection Bureau called out in a report published March 1, 2022. CFPB published the report marking two years into the pandemic, discussing concerns about medical debt collections and reporting that grew during the COVID-19 crisis. Let’s connect the dots on: A joint announcement this week from three major credit agencies,

 

Thinking About Telehealth Through the Lens of Real Estate – Listening to JLL

If you made your living in commercial real estate — and especially, working with hospitals’ and health systems’ office space — would the concept of telehealth be freaking you out right now? If you heed the words of JLL’s 2022 Patient Consumer Survey, you’d chill (at least a bit). The tagline on this paper is, “Convenience and choice drive patient decisions as new digital options take hold.” I was particularly keen to dig into this study based on its sponsoring organization: JLL is a real estate services company serving over a dozen vertical markets — including health care, life sciences,

 

Why #CES2022 Will Be Keynoted By A Health Care Innovator for the First Time

In October 2021, the Consumer Technology Association (CTA) announced that Robert Ford, CEO and President of Abbott, would give a keynote speech at CES 2022, the world’s largest annual convention of the technology industry. “This marks the first time in CES history that a healthcare company will take the mainstage for a keynote at the show,” CTA’s press release stated. I covered this announcement in the Health Populi blog at the time, and today want to double-down on the significance of Ford’s leading presence at #CES2022. When announced, the news was a signal that health care and the larger tech-enabled

 

The 2022 Health Populi TrendCast for Consumers and Health Citizens

I cannot recall a season when so many health consumer studies have been launched into my email inbox. While I have believed consumers’ health engagement has been The New Black for the bulk of my career span, the current Zeitgeist for health care consumerism reflects that futurist mantra: “”We tend to overestimate the effect of a technology in the short run and underestimate the effect in the long run,” coined by Roy Amara, past president of Institute for the Future. That well-used and timely observation is known as Amara’s Law. This feels especially apt right “now” as we enter 2022,

 

The Cost to Cover Health Insurance for a Family in America Is $22,221

Even with growing inflation in the U.S. and post-pandemic job growth in 2021, the cost of health insurance premiums rose faster than either the price of goods or wages. That family health plan premium reached $22,221, an increase of 22% since 2016, we learn in the annual report from Kaiser Family Foundation, 2021 Employer Health Benefits Survey. This report is our go-to encyclopedia of statistics on health insurance year-after-year, surveying companies’ annual health insurance strategies for coverage and tactics for managing spending and workers’ health outcomes. This 2021 update takes into account the impacts and influence of COVID-19 on workers’

 

Support for Drug Price Negotiation Brings Partisans Together in the U.S.

Most U.S. adults across political parties favor allowing the Federal government authority to negotiate for drug prices — even after hearing the arguments against the health policy. Drug price negotiation, say by the Medicare program, is a unifying public policy in the current era of political schisms in America, based on the findings in a special Kaiser Family Foundation (KFF) Health Tracking Poll conducted in late September-early October 2021. Overall, 4 in 5 Americans favor allowing the Federal government negotiating power for prescription drug prices, shown in the first chart from the KFF report. By party, nearly all Democrats agree

 

Consider Mental Health Equity on World Mental Health Day

COVID-19 exacted a toll on health citizens’ mental health, worsening a public health challenge that was already acute before the pandemic. It’s World Mental Health Day, an event marked by global and local stakeholders across the mental health ecosystem. On the global front, the World Health Organization (WHO) describes the universal phenomenon and burden of mental health on the Earth’s people… Nearly 1 billion people have a mental disorder Depression is a leading cause of disability worldwide, impacting about 5% of the world’s population People with severe mental disorders like schizophrenia tend to die as much as 20 years earlier

 

Why CES 2022 Will Be Keynoted by a Health Care Executive

The Consumer Technology Association (CTA) announced that Robert Ford, CEO and President of Abbott, will give a keynote speech at CES 2022, the world’s largest annual convention of the technology industry. This news is a signal that health care and the larger tech-enabled ecosystem that supports health and well-being is embedded in peoples’ everyday lives. Digital health as a category has been a growing feature at CES for over a decade, starting with the early wearable tech era of Fitbit, Nike, Omron and UnderArmour, early exhibitors at CES representing the category. By 2020, the most recent “live, in person” CES,

 

Telehealth is Health: It’s Telehealth Awareness Week

In April 2020, telemedicine morphed into mainstream medical care as hospitals and physicians risk-managed exposure to infection by meeting with patients, virtually, when possible. By March 2020, telehealth channels were replacing visits to doctors and emergency departments as shown in the first chart from the CDC’s report on the early pandemic period. By the spring of 2021, telehealth use stabilized, but health systems had built the processes and policies to deliver on the promise of omni-channel health care — from the patient’s home and hands (via smartphones) into community sites closer-to-home, and returning to brick-and-mortar medical buildings. Welcome to Telehealth

 

New Primary Care, Retail and Tech Entrants Motivating Hospitals to Grow Consumer Chops

Rising costs, generational shifts, digital transformation, and fast-growing investments in new health care models and technologies are forcing change in the legacy health care, noted in the State of Consumerism in Healthcare 2021: Regaining Momentum, from Kaufman, Hall & Associates. As the title of Kaufman Hall’s sixth annual report suggests, health care consumers are evolving — even if the traditional healthcare system hasn’t uniformly responded in lock step with more demanding patients. Kaufman Hall analyzed 100 health care organizations in this year’s consumerism survey to assess their readiness to embrace consumer-centric strategies, understand how the industry prioritizes these approaches, evaluate

 

Pondering Prescription Drugs: Pricing Rx and Going Direct-to-Consumer

There is one health care public policy issue that unites U.S. voters across political party: that is the consumer-facing costs of prescription drugs. With the price of medicines in politicians’ and health citizens’ cross-hairs, the pharmaceutical and biotech industries have responded in many ways to the Rx pricing critiques from consumers (via, for example, Consumer Reports/Consumers Union and AARP), hospitals (through the American Hospital Association), and insurance companies (from AHIP, America’s Health Insurance Plans). The latest poll from the University of Chicago/Harris Public Policy and the Associate Press-NORC Center for Public Affairs Research quantifies the issue cross-party, finding that 74%

 

Health Insurance in Aisle 3: Why a Grocery Chain is Working on Medicare

“You can trust us to help you find the right Medicare coverage for you and your lifestyle,” the tagline reads. What kind of organization would be behind this campaign: a healthcare navigator company, an insurance company, or a social services agency? In fact, it’s a grocery store called Hy-Vee, which launched the “Medicare Aisle” to help consumers living in the eight states in which the chain’s 240+ stores operate to sort through the daunting labyrinth of Medicare choices. “Hy-Vee is a trusted leader in the health and wellness space, and as a retail and specialty pharmacy provider, we are deeply

 

Doctors’ Offices Morph into Bill Collectors As Patients Face Growing Out-Of-Pocket Costs

In the U.S., patients have assumed the role of health care payors with growing co-payments, coinsurance amounts, and deductibles pushing peoples’ out-of-pocket costs up. This has raised the importance of price transparency, which is based on the hypothesis that if patients had access to personally-relevant price/cost information from doctors and hospitals for medical services, and pharmacies and PBMs for prescription drugs, the patient would behave as a consumer and shop around. That hypothesis has not been well proven-out: even though more health care “sellers” on the supply side have begun to post price information for services, patients still haven’t donned

 

Women’s Health Re-shaped by COVID-19

While women continue to outlive men in the U.S. in terms of life expectancy, the COVID-19 pandemic revealed continued healthcare access, physical and mental health disparities, and economic inequities for women in America. I addressed the changing state of post-pandemic women’s health in my latest contribution to the Medecision Liberation blog. This first graphic illustrates how women interacted with the U.S. health system during the pandemic in 2020. These data come from Kaiser Family Foundation’s women’s health survey conducted from the beginning of the pandemic starting March 1, 2020, and discovered that women in poorer or fair more likely went

 

Eli Lilly Bets on U.S. Well-Being at the Olympics

The U.S. Olympic team will be competing in Tokyo for first-place medals across many athletic events, each nation’s most physically-fit citizens going for gold. When it comes to the U.S. ranking on the world roster of population health outcomes, American ranks low on many key metrics, especially given that the U.S. does rank #1 in one key stat: healthcare spending. Reminding us of America’s lowly-placed health outcomes, the Eli Lilly Company is collaborating with Team USA, the US Olympic and Paralympic teams, to promote “Our Collective Health” with the message that, “Watching the success of our athletes will once again

 

CVS Finds Differences in Mental and Behavioral Health Among Men Vs. Women in the Pandemic

As the COVID-19 pandemic shifts to a more endemic phase — becoming part of peoples’ everyday life for months to come — impacts on peoples’ mental health will persist, according to new research from CVS Health in the company’s annual Health Care Insights Study. CVS conducted the annual Health Care Insights Study among 1,000 U.S. adults in March 2021. To complement the consumer study, an additional survey was undertaken among 400 health care providers including primary care physicians and specialists, nurse practitioners, physician assistants, RNs and pharmacists. CVS has been tracking the growing trend of health care consumerism in the

 

Healthy Living Trends Inspired by COVID-19: Retailers, Food, and Consumers’ Growing Self-Care Muscles

“Self-care” took on new meaning and personal work-flows for people living in and through the coronavirus pandemic in the U.S. Acosta, the retail market research pro’s, updated our understanding consumers evolving as COVID-19 Has Elevated the Health and Wellness Trends of the Recent Years, results of a survey conducted among in May 2021. In the U.S., consumers’ take on self-care has most to do with healthy eating and nutrition (for 1 in 2 people), getting regular medical checkups (for 42%), taking exercise, relaxing, using vitamins and supplements, and getting good sleep. Healthy relationships are an integral part of self-care for

 

The Healthcare and Macro-Economic Impacts of Living with Endemic COVID – Listening to Fitch

Getting totally rid of the coronavirus isn’t likely, so we humans must accept the fact that SARS-CoV-2 will be endemic. The economic and healthcare system impacts of this were explored in the Post-Covid Healthcare Landscape, delivered by Fitch Solutions’ Jamie Davies and Beau Noafshar, leaders in the Pharmaceuticals, Healthcare, and Medical Devices groups. I welcomed the opportunity to learn from this team’s approach in weaving together the dynamic issues that help us to plan for the long-tail of COVID-19 and its impact on the economy and prospects for the health care industry and health citizens. The first graph illustrates the

 

What Do Democrats and Republicans Agree On? Allowing Negotiations to Lower Rx Prices

People living in the U.S. have weathered over fifteen months of life-shifts for work, school, prayer, fitness, and social lives. So you might think that the most important public priority for Congress might have something to do with COVID-19, vaccines, or health insurance coverage. But across all priorities, it turns out that prescription drug costs rank higher in Americans’ minds than any other issue in the Kaiser Family Foundation Health Tracking Poll for May 2021. Two-thirds of U.S. adults said that allowing the federal government and private insurance plans to negotiate for lower prices on Rx drugs was their top

 

Trust in Healthcare is Under Stress in the US and Globally, Edelman Finds

You’re stressed, I’m stressed; most of us have felt stress in the COVID-19 era which began in the U.S. in the first quarter of 2020. Nearly eighteen months later, a 2021 Edelman Trust Barometer update finds that consumers’ trust in the health care industry is under stress, too — in the U.S. and around the world. The first chart from the Edelman health care update demonstrates that in most countries polled, health citizens’ trust in health care was buoyed in the first five months of 2020 (January through May): up 18 points in the U.S., 14 points in Canada and

 

Health and Getting Outside – What the 2021 Axios Harris Poll 100 Brands Mean for Health/Care

We want to go outside, drive our cars, shop for groceries, stay and get healthy. These are the key themes coming out of the 2021 Axios Harris Poll 100 on the most visible brands with high (and low) reputations among U.S. consumers. In the top-ranked “excellent” and “very good” brands numbered 1 through 50, we find five core health care brands that were most visible to U.S. consumers: Moderna ranked #3, Pfizer #7, CVS Health #24, Walgreens #46, and Kaiser Permanente #47. The only pure healthcare brand in the bottom 50 was Johnson & Johnson at #72, between Dollar General